![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, December 18, 2019 12:53:24 PM
Recent MIRM News
- Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences • Business Wire • 08/28/2024 08:01:00 PM
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/09/2024 11:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/07/2024 08:11:27 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2024 08:06:00 PM
- Mirum Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update • Business Wire • 08/07/2024 08:01:00 PM
- Mirum Pharmaceuticals to Announce Second Quarter 2024 Financial Results and Host Conference Call on August 7, 2024 • Business Wire • 07/31/2024 08:30:00 PM
- Mirum’s LIVMARLI Now Approved for PFIC in Patients 12 Months and Older • Business Wire • 07/25/2024 12:30:00 PM
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 07/10/2024 11:00:00 PM
- Approbation du LIVMARLI de Mirum Pharmaceuticals dans l'Union européenne pour les patients atteints de PFIC • Business Wire • 07/08/2024 08:46:00 PM
- LIVMARLI von Mirum Pharmaceuticals wird in der Europäischen Union für Patienten mit PFIC zugelassen • Business Wire • 07/08/2024 08:20:00 PM
- Mirum Pharmaceuticals’ LIVMARLI Approved in the European Union for Patients with PFIC • Business Wire • 07/08/2024 12:30:00 PM
- Mirum Submits New Drug Application to FDA for Chenodiol for the Treatment of CTX • Business Wire • 06/28/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/17/2024 12:03:33 PM
- Mirum’s Volixibat Achieves Positive Interim Analyses in VANTAGE PBC and VISTAS PSC Studies • Business Wire • 06/17/2024 12:00:00 PM
- Mirum Pharmaceuticals to Host Investor Call to Share Interim Analysis Results from the Volixibat VANTAGE and VISTAS studies on June 17, 2024 • Business Wire • 06/16/2024 09:00:00 PM
- Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 06/11/2024 02:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 10:23:47 PM
- Langfristige Daten aus den LIVMARLI-Studien von Mirum bei ALGS und PFIC auf dem EASL-Kongress vorgestellt • Business Wire • 06/07/2024 04:04:00 AM
- Les données à long terme des études LIVMARLI de Mirum sur l’ALGS et la PFIC présentées au congrès de l’EASL • Business Wire • 06/07/2024 04:04:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:38:26 PM
- Long-Term Data from Mirum’s LIVMARLI Studies in ALGS and PFIC Highlighted at EASL Congress • Business Wire • 06/06/2024 01:30:00 PM
- Mirum Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference • Business Wire • 06/05/2024 08:05:00 PM
- Mirum Pharmaceuticals: positive CHMP-Stellungnahme für LIVMARLI® (Maralixibat) als orale Lösung zur Behandlung von PFIC bei Patienten ab einem Alter von drei Monaten • Business Wire • 05/31/2024 09:02:00 PM
- Mirum Pharmaceuticals annonce un avis favorable du CHMP pour la solution orale LIVMARLI® (maralixibat) dans le traitement des patients atteints de CIFP âgés de trois mois et plus • Business Wire • 05/31/2024 05:12:00 PM
- Mirum Pharmaceuticals Announces Positive CHMP Opinion for LIVMARLI® (maralixibat) Oral Solution for the Treatment of PFIC in Patients Three Months of Age and Older • Business Wire • 05/31/2024 12:30:00 PM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM